Primary human papillomavirus DNA screening with cytology triage in a routine organized screening program detects more cervical intraepithelial neoplasia III+ lesions in all age groups than conventional cytology, according to new study findings.
Primary human papillomavirus (HPV) DNA screening with cytology triage in a routine organized screening program detects more cervical intraepithelial neoplasia (CIN) III+ lesions in all age groups than conventional cytology, according to the findings of a recent randomized, population-based, longitudinal study from Finland.
In the study, which included data on more than 58,000 women, the relative rate of CIN III+ lesions in the HPV group versus the conventional group was 1.44 (95% CI, 1.01-2.05) among all women invited to participate and 1.77 (95% CI, 1.16-2.74) among those who were actually screened. The rate of cervical cancer between arms was 0.75 (95% CI, 0.25-2.16) among invitees and 1.98 (95% CI, 0.52-9.38) among attendees.
Among women with a normal or negative test result, the relative rate between groups of subsequent CIN III+ was 0.28 (95% CI, 0.04-1.17), suggesting a lower rate of CIN III+ for HPV screening than for conventional cytology.
Anttila A, Kotaniemi-Talonen L, Leionen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organized screening programme. BMJ. 2010;340:c1804.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More